Patented Algorithm Designed to Help Identify Otherwise Dangerous Prostate Tumors Earlier Using Repeat Blood Test Results Licensing Agreement Expands 20/20 BioLabs’ AI-Enabled Multi-Cancer Early ...
A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...
For many men, a prostate cancer scare starts with one number. A PSA result comes back high, and ...
Prostate biopsies in Florida typically cost between $4,864 and $5,334 per procedure, representing a significant burden when a majority of procedures yield benign findings. If the study’s objectives ...
GAITHERSBURG, Md., May 12, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (“20/20”) (Nasdaq: AIDX), an early market entrant in cutting-edge, AI powered laboratory-based blood tests for the early ...